- Home
- HSIC vs BMRN Comparison
HSIC vs BMRN Comparison
Compare HSIC & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSIC | BMRN |
|---|---|---|
| Founded | 1932 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.0B |
| IPO Year | 1995 | 1999 |
Fundamental Metrics
Financial Performance| Metric | HSIC | BMRN |
|---|---|---|
| Price | $76.69 | $61.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 19 |
| Target Price | $76.50 | ★ $88.68 |
| AVG Volume (30 Days) | 1.3M | ★ 3.9M |
| Earning Date | 11-04-2025 | 10-27-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 30.70 | ★ 59.53 |
| EPS | ★ 3.17 | 2.68 |
| Revenue | ★ $12,938,000,000.00 | $3,094,001,000.00 |
| Revenue This Year | $5.35 | $13.35 |
| Revenue Next Year | $3.34 | $9.06 |
| P/E Ratio | $24.48 | ★ $22.11 |
| Revenue Growth | 3.51 | ★ 12.39 |
| 52 Week Low | $60.56 | $50.76 |
| 52 Week High | $82.49 | $73.51 |
Technical Indicators
Market Signals| Indicator | HSIC | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 61.55 | 67.91 |
| Support Level | $76.27 | $51.50 |
| Resistance Level | $78.10 | $63.89 |
| Average True Range (ATR) | 1.32 | 1.95 |
| MACD | -0.04 | 0.81 |
| Stochastic Oscillator | 75.00 | 76.14 |
Price Performance
Historical ComparisonAbout HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.